A look back at Pharma in 2010

With 2010 coming to a close, FiercePharma is publishing our annual year-in-review issue. We're taking a look back at the past 12 months to identify the major trends--such as recalls, settlements and the emerging markets grab--that shaped the pharma industry this year.

FiercePharma is taking our annual year-end break and won't be published tomorrow or the last week of December. But you can visit www.fiercepharma.com for breaking news or check out our special reports archive to catch up on articles you may have missed. We'll be back to our regular schedule on Monday, January 3rd and look forward to sharing another year of pharma news with you in 2011. Happy holidays! - Maureen (twitter | email)

Suggested Articles

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Moderna is entering an important time, its CEO says. And the company is doing so with a new finance chief from Big Biotech.

A new NEJM study found taking hydroxychloroquine after COVID-19 exposure doesn't reduce the risk of an infection. But questions remain.